Concord Medical Services Stock Current Liabilities
CCM Stock | USD 0.55 0.04 6.27% |
Concord Medical Services fundamentals help investors to digest information that contributes to Concord Medical's financial success or failures. It also enables traders to predict the movement of Concord Stock. The fundamental analysis module provides a way to measure Concord Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Concord Medical stock.
As of the 28th of March 2024, Non Current Liabilities Total is likely to grow to about 3.5 B, while Total Current Liabilities is likely to drop about 733.9 M. Concord | Current Liabilities |
Concord Current Liabilities Analysis
Concord Medical's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Concord Medical Current Liabilities | 1.51 B |
Most of Concord Medical's fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Concord Medical Services is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Concord Current Liabilities Driver Correlations
Understanding the fundamental principles of building solid financial models for Concord Medical is extremely important. It helps to project a fair market value of Concord Stock properly, considering its historical fundamentals such as Current Liabilities. Since Concord Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Concord Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Concord Medical's interrelated accounts and indicators.
Click cells to compare fundamentals
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition |
Concord Total Current Liabilities
Total Current Liabilities |
|
In accordance with the recently published financial statements, Concord Medical Services has a Current Liabilities of 1.51 B. This is 13.77% lower than that of the Health Care Providers & Services sector and significantly higher than that of the Health Care industry. The current liabilities for all United States stocks is 80.88% higher than that of the company.
Concord Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Concord Medical's direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Concord Medical could also be used in its relative valuation, which is a method of valuing Concord Medical by comparing valuation metrics of similar companies.Concord Medical is currently under evaluation in current liabilities category among related companies.
Concord Fundamentals
Return On Equity | -0.31 | ||||
Return On Asset | -0.0498 | ||||
Profit Margin | (0.76) % | ||||
Operating Margin | (0.75) % | ||||
Current Valuation | 444.01 M | ||||
Shares Outstanding | 43.42 M | ||||
Shares Owned By Insiders | 17.99 % | ||||
Shares Owned By Institutions | 0.10 % | ||||
Number Of Shares Shorted | 2.2 K | ||||
Price To Earning | (3.90) X | ||||
Price To Book | 3.00 X | ||||
Price To Sales | 0.04 X | ||||
Revenue | 472.08 M | ||||
Gross Profit | (152.41 M) | ||||
EBITDA | (581.17 M) | ||||
Net Income | (768.99 M) | ||||
Cash And Equivalents | 157.39 M | ||||
Cash Per Share | 1.72 X | ||||
Total Debt | 3.24 B | ||||
Debt To Equity | 1.25 % | ||||
Current Ratio | 0.71 X | ||||
Book Value Per Share | (42.96) X | ||||
Cash Flow From Operations | (216.69 M) | ||||
Short Ratio | 0.90 X | ||||
Earnings Per Share | (1.49) X | ||||
Target Price | 1.2 | ||||
Number Of Employees | 918 | ||||
Beta | -0.21 | ||||
Market Capitalization | 24.93 M | ||||
Total Asset | 6 B | ||||
Retained Earnings | (3.77 B) | ||||
Working Capital | (361.44 M) | ||||
Current Asset | 1.51 B | ||||
Current Liabilities | 1.51 B | ||||
Z Score | -1.19 | ||||
Net Asset | 6 B |
About Concord Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Concord Medical Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Concord Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Concord Medical Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Last Reported | Projected for 2024 | ||
Total Current Liabilities | 1.3 B | 733.9 M | |
Non Current Liabilities Total | 3.3 B | 3.5 B | |
Non Current Liabilities Other | 3.4 M | 3.2 M |
Pair Trading with Concord Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Concord Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Concord Medical will appreciate offsetting losses from the drop in the long position's value.Moving together with Concord Stock
0.85 | TFX | Teleflex Incorporated Financial Report 2nd of May 2024 | PairCorr |
Moving against Concord Stock
0.86 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
0.86 | MDWD | Mediwound Downward Rally | PairCorr |
0.76 | SNDA | Sonida Senior Living Report 4th of April 2024 | PairCorr |
0.7 | RNLX | Renalytix AI Report 4th of April 2024 | PairCorr |
0.55 | MDGL | Madrigal Pharmaceuticals Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Concord Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Concord Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Concord Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Concord Medical Services to buy it.
The correlation of Concord Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Concord Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Concord Medical Services moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Concord Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Concord Medical Piotroski F Score and Concord Medical Altman Z Score analysis. Note that the Concord Medical Services information on this page should be used as a complementary analysis to other Concord Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Complementary Tools for Concord Stock analysis
When running Concord Medical's price analysis, check to measure Concord Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Concord Medical is operating at the current time. Most of Concord Medical's value examination focuses on studying past and present price action to predict the probability of Concord Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Concord Medical's price. Additionally, you may evaluate how the addition of Concord Medical to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |
Is Concord Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.49) | Revenue Per Share 14.017 | Quarterly Revenue Growth 0.972 | Return On Assets (0.05) | Return On Equity (0.31) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.